EssilorLuxottica SA posted sales ahead of estimates, driven by a strong performance in North America and the consolidation of ...

Ray-Ban maker EssilorLuxottica posted higher sales for the fourth quarter fueled by strong growth in North America and China.

Sound sales growth and margin expansion in 2024 Smartglasses as a new driver, Nuance off to a promising start Group revenue at constant exchange rates1 +9.2% in Q4 and +6.0% in the FYNorth America ...

Jefferies upgraded EssilorLuxottica (ESLOY) to Buy from Hold with a price target of EUR 310, up from EUR 195. The company is a “structural ...

The agreement allows the group to expand its portfolio of ophthalmic instruments and solutions, further strengthening its ...

In a report released today, Zuzanna Pusz from UBS maintained a Hold rating on EssilorLuxottica SA (0OMK – Research Report). The company’s ...

A Thai woman was arrested for her alleged involvement in Thailand's largest romance scam, which defrauded a company of 6.3 billion baht.

Orathai’s case is linked to an investigation into a senior executive who has allegedly defrauded her company Essilor ...

Europe medical device market was valued at $144.4 billion in 2022 and will grow by 4.7% annually over 2022-2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of ...

North America medical device market is projected to grow by 3.9% annually in the forecast period and reach $ 282.3 billion by 2032, driven by the prevalence of infectious diseases as well as the ...

EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its ...

Investing.com -- RBC Capital Markets has upgraded EssilorLuxottica (EPA: ESLX) to "outperform," citing strong fundamentals ...